Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Itvisma

Neuroscience

Neuroscience Today—April 29, 2026

This week’s Neuroscience update highlights regulatory actions, clinical…

by Ruairi McEntee

Rare Disease news

Rare Disease Today—November 27, 2025

This week’s rare diseases update spotlights key developments, regulatory…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Immunology Today—June 3, 2026
Neuroscience Today—June 3, 2026
Rallybio Avenzo Merger and $215M Financing | Lucid Diligence Brief
Obesity Today—June 2, 2026
Servier Edgewise Sevasemten Deal | Lucid Diligence Brief

Tags

AANAM Aging Research Albert Einstein College of Medicine Alto Neuroscience Apertura Gene Therapy Artificial intelligence in medicine ATS 2025 Bavarian Nordic Bone-Viva Bone Marrow Transplant CACNA1A-Related Disorders CNS disorders Competitive Intelligence Tools Continuous glucose monitoring technologies Dravet Syndrome Grit Biotechnologies Gut Brain Axis hearing loss HIV prevention Inflammatory Pain Legacy Healthcare LQ Ventures MATTERHORN Trial MicuRx Nexplanon Oats Oncology Research Paediatric plaque psoriasis pain management Patient Narrative pediatric rare diseases PM2.5 air pollution Postpartum Depression Premature Menopause rare conditions Renal Denervation Rituxan RNA RNA therapies ROCTAVIAN Schizophrenia Research TAVI thrombotic stroke TOGETHER-PsO Trial wearable health

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Immunology Today—June 3, 2026
Neuroscience Today—June 3, 2026
Rallybio Avenzo Merger and $215M Financing | Lucid Diligence Brief
Obesity Today—June 2, 2026
Servier Edgewise Sevasemten Deal | Lucid Diligence Brief

TAGS

AANAM Aging Research Albert Einstein College of Medicine Alto Neuroscience Apertura Gene Therapy Artificial intelligence in medicine ATS 2025 Bavarian Nordic Bone-Viva Bone Marrow Transplant CACNA1A-Related Disorders CNS disorders Competitive Intelligence Tools Continuous glucose monitoring technologies Dravet Syndrome Grit Biotechnologies Gut Brain Axis hearing loss HIV prevention Inflammatory Pain Legacy Healthcare LQ Ventures MATTERHORN Trial MicuRx Nexplanon Oats Oncology Research Paediatric plaque psoriasis pain management Patient Narrative pediatric rare diseases PM2.5 air pollution Postpartum Depression Premature Menopause rare conditions Renal Denervation Rituxan RNA RNA therapies ROCTAVIAN Schizophrenia Research TAVI thrombotic stroke TOGETHER-PsO Trial wearable health

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy